Thermo Fisher Scientific said last week that it has completed its acquisition of Finnish PCR products provider Finnzymes.

Thermo Fisher first announced the acquisition in early February. At the time, a Thermo official said that the acquisition was expected to bolster Thermo's PCR product portfolio, in particular by providing the company with its first PCR instrument platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.